MYL7 and cancer: Transgenic fish that overexpresses ribose-5-phosphate isomerase A (RPIA) under the control of an intestinal fatty acid-binding protein (ifabp) promoter (Tg(ifabp:RPIA; myl7:EGFP) developed cancer in the gut at ~3 months of age [25].